TrialMuscle & nerve2025

Safety Extension Study of Edaravone Oral Suspension in Patients With Amyotrophic Lateral Sclerosis for up to an Additional 96 Weeks of Treatment.

Angela Genge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.